February 1, 2017 / 6:27 AM / 3 years ago

CORRECTED-TABLE-Kobayashi Pharmaceutical - 9-month group results

(Corrects current period as follows because of accounting period change)
Feb 1 (Reuters)- 
Kobayashi Pharmaceutical Co Ltd 
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)

               9 months ended    Year ended       Year to       NEXT
                Dec 31, 2016    Mar 31, 2016   Dec 31, 2017     YEAR
                   LATEST         YEAR-AGO        COMPANY      COMPANY
                   RESULTS         RESULTS       FORECAST    H1 FORECAST
  Sales            120.05          137.21         150.00        63.50
                                 (+6.9 pct)
  Operating         17.41           18.26          20.00         7.60
                                 (+1.9 pct)
  Recurring         19.50           17.95          21.00         7.10
                                 (-4.7 pct)
  Net               14.32           13.47          15.10         5.00
                                 (+8.2 pct)
  EPS            179.12 yen      165.56 yen     191.64 yen    63.46 yen
  EPS Diluted    178.86 yen      165.30 yen
  Ann Div         52.00 yen       96.00 yen      52.00 yen
  -Q2 Div         25.00 yen       48.00 yen      26.00 yen
  -Q4 Div         27.00 yen       48.00 yen      26.00 yen

NOTE - Kobayashi Pharmaceutical Co Ltd.
Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below